NEW YORK (GenomeWeb News) — Open Biosystems will sell and distribute Codon Devices’ BioFAB synthetic genetics platform in North America, Codon said Monday.
Codon said the agreement is part of its effort to extend its BioFAB platform to a broader market. Previously, Codon offered BioFAB only to customers able to meet minimum order requirements.
Under the terms of the agreement, Open Biosystems will sell and distribute Codon Devices' gene-synthesis offering to researchers with needs that fall below its “minimum order threshold.”
Codon said that the partnership with Open Biosystems is expected to attract a broad range of new customers and will help it expand its presence within academic, government, and other non-profit institutions.
Financial terms of the agreement were not released.